Is the 250% Carisma Therapeutics Stock (CARM) Surge a Sucker's Rally?
Carisma Therapeutics (CARM) stock underwent a massive rally on Tuesday despite a lack of news from the biopharmaceutical company. This may have investors wondering what's going on with CARM stock today.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
It appears that Carisma Therapeutics stock saw a 'sucker's rally' or 'dead cat bounce' today. This is when a stock that has suffered strong negative momentum undergoes an unexpected rally. While that might see some traders take interest in CARM stock, they should first note that the company is considering strategic alternatives, including the potential wind-down of its operations.
CARM stock was up 247.71% during pre-market trading on Tuesday. However, the stock has dropped 46% year-to-date and 81.71% over the past 12 months.
Is Carisma Therapeutics Stock a Buy, Sell, or Hold?
Spark, TipRanks' AI analyst, rates Carisma Therapeutics stock an Underperform (40) with no price target. The company faces 'significant financial challenges, as evidenced by its poor financial performance and valuation metrics.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
14 minutes ago
- Business Insider
Huatai Securities Sticks to Their Buy Rating for CITIC Securities Co (CIIHF)
Huatai Securities analyst maintained a Buy rating on CITIC Securities Co (CIIHF – Research Report) yesterday and set a price target of HK$26.91. The company's shares closed last Wednesday at $3.03. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The word on The Street in general, suggests a Hold analyst consensus rating for CITIC Securities Co. The company has a one-year high of $3.26 and a one-year low of $1.25. Currently, CITIC Securities Co has an average volume of 1,500.
Business Insider
14 minutes ago
- Business Insider
Huatai Securities Sticks to Their Buy Rating for China Coal Energy Co (CCOZF)
Huatai Securities analyst maintained a Buy rating on China Coal Energy Co (CCOZF – Research Report) yesterday and set a price target of HK$9.84. The company's shares closed last Monday at $1.07. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The word on The Street in general, suggests a Hold analyst consensus rating for China Coal Energy Co. The company has a one-year high of $1.45 and a one-year low of $0.88. Currently, China Coal Energy Co has an average volume of 9,633.
Business Insider
14 minutes ago
- Business Insider
Huatai Securities Reaffirms Their Buy Rating on Industrial and Commercial Bank of China (IDCBF)
In a report released yesterday, from Huatai Securities maintained a Buy rating on Industrial and Commercial Bank of China (IDCBF – Research Report), with a price target of HK$6.71. The company's shares closed last Wednesday at $0.80. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Currently, the analyst consensus on Industrial and Commercial Bank of China is a Moderate Buy with an average price target of $0.89, representing an 11.25% upside. In a report released on June 16, DBS also reiterated a Buy rating on the stock with a HK$7.30 price target. The company has a one-year high of $0.84 and a one-year low of $0.50. Currently, Industrial and Commercial Bank of China has an average volume of 20.62K.
